171 related articles for article (PubMed ID: 11779672)
1. Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients.
Shimoyama N; Shimoyama M
J Pain Symptom Manage; 2002 Jan; 23(1):73-6. PubMed ID: 11779672
[TBL] [Abstract][Full Text] [Related]
2. Effect of nebulized furosemide in terminally ill cancer patients with dyspnea.
Kohara H; Ueoka H; Aoe K; Maeda T; Takeyama H; Saito R; Shima Y; Uchitomi Y
J Pain Symptom Manage; 2003 Oct; 26(4):962-7. PubMed ID: 14575057
[TBL] [Abstract][Full Text] [Related]
3. Re: nebulized furosemide for dyspnea in terminal cancer patients.
Stone P; Rix ; Kurowska A; Tookman
J Pain Symptom Manage; 2002 Sep; 24(3):274-5; author reply 275-6. PubMed ID: 12458098
[No Abstract] [Full Text] [Related]
4. Nebulized furosemide for the management of dyspnea: does the evidence support its use?
Newton PJ; Davidson PM; Macdonald P; Ollerton R; Krum H
J Pain Symptom Manage; 2008 Oct; 36(4):424-41. PubMed ID: 18468839
[TBL] [Abstract][Full Text] [Related]
5. Nebulized frusemide for dyspnoea.
Stone P; Kurowska A; Tookman A
Palliat Med; 1994; 8(3):258. PubMed ID: 7952379
[No Abstract] [Full Text] [Related]
6. Nebulized medications for the treatment of dyspnea: a literature review.
Boyden JY; Connor SR; Otolorin L; Nathan SD; Fine PG; Davis MS; Muir JC
J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):1-19. PubMed ID: 24914770
[TBL] [Abstract][Full Text] [Related]
7. The adjunctive effect of nebulized furosemide in COPD exacerbation: a randomized controlled clinical trial.
Sheikh Motahar Vahedi H; Mahshidfar B; Rabiee H; Saadat S; Shokoohi H; Chardoli M; Rahimi-Movaghar V
Respir Care; 2013 Nov; 58(11):1873-7. PubMed ID: 23650431
[TBL] [Abstract][Full Text] [Related]
8. Nebulised frusemide for the symptomatic treatment of end-stage congestive heart failure.
Towers KA; Bardsley KA; Macdonald PS
Med J Aust; 2010 Nov; 193(9):555. PubMed ID: 21034394
[No Abstract] [Full Text] [Related]
9. Effect of inhaled furosemide and torasemide on bronchial response to ultrasonically nebulized distilled water in asthmatic subjects.
Foresi A; Pelucchi A; Mastropasqua B; Cavigioli G; Carlesi RM; Marazzini L
Am Rev Respir Dis; 1992 Aug; 146(2):364-8. PubMed ID: 1489126
[TBL] [Abstract][Full Text] [Related]
10. Furosemide inhalation in dyspnea of mustard gas-exposed patients: a triple-blind randomized study.
Panahi Y; Motiei-Langroudi R; Alaeddini F; Naghizadeh MM; Aslani J; Ghanei M
Inhal Toxicol; 2008 Jul; 20(9):873-7. PubMed ID: 18645727
[TBL] [Abstract][Full Text] [Related]
11. Effect of inhaled furosemide and cromolyn on bronchoconstriction induced by ultrasonically nebulized distilled water in asthmatic subjects.
Siffredi M; Mastropasqua B; Pelucchi A; Chiesa M; Marazzini L; Foresi A
Ann Allergy Asthma Immunol; 1997 Feb; 78(2):238-43. PubMed ID: 9048536
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease.
Ong KC; Kor AC; Chong WF; Earnest A; Wang YT
Am J Respir Crit Care Med; 2004 May; 169(9):1028-33. PubMed ID: 14977622
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia.
Prabhu VG
Pediatrics; 1997 Sep; 100(3 Pt 1):420-1. PubMed ID: 9304111
[No Abstract] [Full Text] [Related]
14. Nebulized opioids for the palliation of dyspnea in terminally ill patients.
Afolabi TM; Nahata MC; Pai V
Am J Health Syst Pharm; 2017 Jul; 74(14):1053-1061. PubMed ID: 28687551
[TBL] [Abstract][Full Text] [Related]
15. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
[TBL] [Abstract][Full Text] [Related]
16. The role of inhaled opioids and furosemide for the treatment of dyspnea.
Kallet RH
Respir Care; 2007 Jul; 52(7):900-10. PubMed ID: 17594733
[TBL] [Abstract][Full Text] [Related]
17. A phase I/II study of nebulized morphine-6-glucuronide in patients with cancer-related breathlessness.
Quigley C; Joel S; Patel N; Baksh A; Slevin M
J Pain Symptom Manage; 2002 Jan; 23(1):7-9. PubMed ID: 11779662
[No Abstract] [Full Text] [Related]
18. Inhaled furosemide for relief of air hunger versus sense of breathing effort: a randomized controlled trial.
Grogono JC; Butler C; Izadi H; Moosavi SH
Respir Res; 2018 Sep; 19(1):181. PubMed ID: 30236110
[TBL] [Abstract][Full Text] [Related]
19. Controlled Delivery of 80 mg Aerosol Furosemide Does Not Achieve Consistent Dyspnea Relief in Patients.
Hallowell RW; Schwartzstein R; O'Donnell CR; Sheridan A; Banzett RB
Lung; 2020 Feb; 198(1):113-120. PubMed ID: 31728632
[TBL] [Abstract][Full Text] [Related]
20. Nebulized hydromorphone for dyspnea in hospice care of advanced cancer.
Sarhill N; Walsh D; Khawam E; Tropiano P; Stahley MK
Am J Hosp Palliat Care; 2000; 17(6):389-91. PubMed ID: 11886040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
